B. Jasani

发表

Metallothionein expression in duct carcinoma in situ of the breast.

K. Horgan, K. Schmid, A. Douglas-Jones, 1995, Human pathology.

Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma

B. Jasani, L. Campbell, K. Edwards, 2008, British Journal of Cancer.

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

S. Duffy, A. Howell, I. Dos Santos Silva, 2013, Breast Cancer Research.

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer.

B. Jasani, A. Rhodes, A. Dodson, 2002, American journal of clinical pathology.

Impact of Analytical Variables in Breast Cancer Biomarker Analysis

B. Jasani, A. Warford, 2016 .

Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry

A. Bankfalvi, W. Böcker, K. Schmid, 1994, The Journal of pathology.

Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays.

L. Bobrow, D. Barnes, B. Jasani, 2001, American journal of clinical pathology.

Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma.

A. Douglas-Jones, B. Jasani, J. Morgan, 2001, Journal of clinical pathology.

Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening

D. Barnes, B. Jasani, K. Miller, 2000, Journal of clinical pathology.

Demonstration of reduced in vivo surface expression of activating mutant thyrotrophin receptors in thyroid sections.

B. Jasani, D. Fuhrer, M. Wheeler, 2002, European journal of endocrinology.

Further evaluation of immunocytochemical staining in the diagnosis of early myocardial ischaemic/hypoxic damage.

B. Jasani, S. Leadbeatter, H. Wawman, 1990, Forensic Science International.

Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid.

B. Jasani, E. D. Williams, H. R. Harach, 1983, Journal of clinical pathology.

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

W. Carney, B. Jasani, Dirk Bernhardt, 2013, Biomarkers in cancer.

Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.

M. Tötsch, W. Böcker, K. Schmid, 1995, British Journal of Cancer.

Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH.

I. Ellis, B. Jasani, F. Campbell, 2009, American journal of clinical pathology.

Glutathione S‐transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma

G. Betton, B. Jasani, D. Riccardi, 2011, Histopathology.

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

M. Salto‐Tellez, P. Hamilton, Peter Hamilton, 2015, Journal of Translational Medicine.

The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer.

M. Mason, A. Clayton, B. Jasani, 2005, Vaccine.

Pre-Analytic Phase: Test Selection; Specimen Acquisition and Handling

Clive R. Taylor, B. Jasani, R. Huss, 2021, Precision Cancer Medicine.

IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS

A. Campbell, B. Jasani, B. Morgan, 1989, Neuropathology and applied neurobiology.

Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory.

B. Jasani, M. Ibrahim, A. Dodson, 2008, American journal of clinical pathology.

Association of SV40 with human tumours.

A. Gazdar, L. Mutti, C. Miller, 2001, Seminars in cancer biology.

Simian virus 40 detection in human mesothelioma: reliability and significance of the available molecular evidence.

M. Mason, D. Wynford‐Thomas, C. Jones, 2001, Frontiers in bioscience : a journal and virtual library.

The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma.

A. Douglas-Jones, B. Jasani, J. Morgan, 2002, Journal of clinical pathology.

Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification.

S. Knuutila, A. Scarpa, A. Sapino, 2015, American journal of cancer research.

HER 2 Gene Amplification in Breast Cancer

J. Bartlett, B. Jasani, F. Campbell, 2012 .

A UK NEQAS ISH multicenter ring study using the Ventana HER2 dual-color ISH assay.

N. Collins, B. Jasani, F. Campbell, 2011, American journal of clinical pathology.

Best Practice No 176

I. Ellis, M. Dowsett, S. Humphreys, 2004, Journal of Clinical Pathology.

Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial

M. D. James, R. Butler, P. Quirke, 2015, Journal of Clinical Pathology.

FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing

R. Butler, P. Quirke, B. Jasani, 2022, Journal of Clinical Pathology.

Intimal proliferation in an organ culture of human saphenous vein.

G. Angelini, A. Bryan, B. Jasani, 1990, The American journal of pathology.

Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.

B. Jasani, J. Wagner, A. Gibbs, 1985, Thorax.

Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy

I. Modlin, B. Jasani, J. Neal, 2011, Purinergic Signalling.

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

M. Mason, A. Clayton, B. Jasani, 2005, Cancer research.

Recovery of CD 8 + T-Cell Function During Systemic Chemotherapy in Advanced Ovarian Cancer

M. Mason, A. Clayton, B. Jasani, 2005 .

Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology.

M. Varma, P. Tamboli, M. Amin, 2002, American journal of clinical pathology.

Use of anti-platelet-endothelial cell adhesion molecule-1 antibody in the control of disease progression in established collagen-induced arthritis in DBA/1J mice.

B. Jasani, Y. Okada, Toshimitsu Yamada, 2002, Japanese journal of pharmacology.

Immunohistochemical identification of prolactin and 24K protein in secretory endometrium.

S. Walker, B. Jasani, G. Newman, 1986, Fertility and sterility.

Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C cells using monoclonal antimetallothionein antibody E9

M. Tötsch, W. Böcker, K. Schmid, 1994, Endocrine Pathology.

Possible role of tissue‐bound calcium ions in citrate‐mediated high‐temperature antigen retrieval

K. Schmid, B. Jasani, J. Morgan, 1994, The Journal of pathology.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

A. Fiander, B. Jasani, Malcolm Adams, 2007, Vaccine.

Description and Interpretation of Results; The Pathology Report

Clive R. Taylor, B. Jasani, R. Huss, 2021, Precision Cancer Medicine.

Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study

B. Jasani, R. Buettner, H. Schildhaus, 2020 .

Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions.

B. Jasani, D. Fuhrer, M. Wheeler, 2001, Thyroid : official journal of the American Thyroid Association.

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.

B. Jasani, H. Navabi, Malcolm Adams, 2009, Vaccine.

HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy.

A. Scarpa, A. Nottegar, G. Tortora, 2013, Anticancer research.

The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

G. Zamboni, G. Tortora, J. Furlanetto, 2013, Journal of Cancer Research and Clinical Oncology.

Analytical Phase: Principles for Immunohistochemistry (IHC)

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Evolution of the Total Test Approach to Tissue Based Pathological Analysis

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Chromogranin A and B and Secretogranin II in Medullary Carcinomas of the Thyroid

K. Schmid, B. Jasani, E. Williams, 1987, The American journal of surgical pathology.

HYPOTHESIS ON FUNCTIONAL INADEQUACY OF THIOREDOXIN AND RELATED SYSTEMS IN PREECLAMPSIA

R. W. Shaw, B. Jasani, L. Neale, 1997 .

Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis.

B. Jasani, V. Chatterjee, M. Ludgate, 2003, Thyroid : official journal of the American Thyroid Association.

The use of vimentin antibodies in the diagnosis of malignant mesothelioma

B. Jasani, A. Gibbs, N. D. Thomas, 2004, Virchows Archiv A.

CA125inovarian tumourtissue atsecond laparotomy

B. Jasani, G. Williams, M. Shelley, 1989 .

Immunocytochemical diagnosis of early myocardial ischaemic/hypoxic damage.

B. Jasani, S. Leadbeatter, H. Wawman, 1989, Forensic science international.

Multiple hormone storage by ‘polycrine’ cells in the pancreas (from a case of nesidioblastosis)

B. Jasani, E. Williams, G. Newman, 1986, The Histochemical Journal.

Immunogold electron-microscopic localisation of calpain I in skeletal muscle of rats

J. Kay, B. Jasani, N. Yoshimura, 2004, Cell and Tissue Research.

Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.

B. Jasani, G. Williams, M. Shelley, 1988, Gynecologic oncology.

Immunocytochemically detectable metallothionein in granulation tissue surrounding mucosal ulceration

A. Douglas-Jones, B. Jasani, N. D. Thomas, 2005, The Histochemical Journal.

External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme

I. Ellis, B. Jasani, E. Kay, 2006, Journal of Clinical Pathology.

Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function

B. Jasani, L. Campbell, M. Gumbleton, 1999, Cell and Tissue Research.

Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch™ BLN Assay in the operating room: results of the Cardiff study

R. Newcombe, R. Mansel, A. Douglas-Jones, 2009, Breast Cancer Research and Treatment.

Regressing atypical histiocytosis, a regressing cutaneous phase of ki‐i‐positive anaplastic large cell lymphoma. Immunocytochemical, nucleic acid, and cytogenetic studies of a new case in view of current opinion

B. Jasani, P. Holt, R. Motley, 1992, Cancer.

Use of monoclonal antihapten antibodies for immunolocalisation of tissue antigens

B. Jasani, E. Williams, D. W. Thomas, 1981, Journal of clinical pathology.

Immunohistochemical detection of metallothionein.

B. Jasani, M. Elmes, 1991, Methods in enzymology.

High temperature antigen retrieval and loss of nuclear morphology: a comparison of microwave and autoclave techniques.

N. Hunt, B. Jasani, R. Attanoos, 1996, Journal of clinical pathology.

Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

B. Jasani, Jill Walker, W. Waelput, 2020, Diagnostic Pathology.

An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations

B. Jasani, S. Andrew, 1987, The Histochemical Journal.

Synchronous duodenal neuroendocrine tumours in von Recklinghausen's disease—a case report of co‐existing gangliocytic paraganglioma and somatostatin‐rich glandular carcinoid

B. Jasani, G. Williams, E. Williams, 1987, Histopathology.

Glandular duodenal carcinoid--a somatostatin rich tumour with neuroendocrine associations.

B. Jasani, G. Williams, G. Newman, 1984, Journal of clinical pathology.

DNA and enzyme studies on chorionic villi for use in antenatal diagnosis.

D. Shaw, P. Harper, B. Jasani, 1984, Clinica chimica acta; international journal of clinical chemistry.

A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.

M. Mason, A. Clayton, B. Jasani, 2009, Vaccine.

Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms

C. D'Arrigo, J. Rüschoff, B. Jasani, 2018, Modern Pathology.

The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology

B. Jasani, S. Schöniger, 2022, Animals : an open access journal from MDPI.

Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue

S. Blasius, A. Bankfalvi, W. Böcker, 1995, The Histochemical Journal.

Variation in rates of oestrogen receptor positivity in breast cancer again

B. Jasani, K. Miller, A. Rhodes, 2002, BMJ : British Medical Journal.

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

D. Barnes, B. Jasani, A. Rhodes, 2000, Journal of clinical pathology.

HER2 gene amplification in breast cancer: a rogues' gallery of challenging diagnostic cases: UKNEQAS interpretation guidelines and research recommendations.

J. Bartlett, B. Jasani, F. Campbell, 2012, American journal of clinical pathology.

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

I. Ellis, S. Pinder, B. Jasani, 2011, Journal of Clinical Pathology.

Use of epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab (cet) in combination with oxaliplatin (Ox) and 5FU in the first-line treatment of advanced colorectal cancer (aCRC).

M. D. James, B. Jasani, J. Cheadle, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Reliability of FISH Versus Brightfield Dual-probe In Situ Hybridization (BDISH) for Frontline Assessment of HER2 Status in Breast Cancer Samples in a Community Setting: Influence of Poor Tissue Preservation

B. Jasani, H. Gobbi, L. De Brot, 2012, The American journal of surgical pathology.

Immunohistologically definable light chain restriction in autoimmune disease

B. Jasani, 1988 .

Histological demonstration of immunoreactive zinc metallothionein in liver and ileum of rat and man

B. Jasani, M. Webb, M. Elmes, 1985, The Histochemical Journal.

The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?

B. Jasani, A. Rhodes, Bharat Jasani, 2008, Journal of Clinical Pathology.

The immunocytochemical demonstration of a relative lack of nerve fibres in the atrioventricular node and bundle of His in the sudden infant death syndrome (SIDS).

B. Jasani, G. Vujanić, P. Berry, 1994, Forensic science international.

Silver Development in Microscopy and Bioanalysis: a New Versatile Formulation for Modern Needs

B. Jasani, G. Newman, 1998, The Histochemical Journal.

Study of childhood renal tumours using a monoclonal antibody to Tamm-Horsfall protein.

H. B. Marsden, H. Marsden, B. Jasani, 1987, Journal of clinical pathology.

Histogenesis of haemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome.

S. Ismail, B. Jasani, G. Cole, 1985, Journal of clinical pathology.

Deep Penetrating Dermatofibroma Versus Dermatofibrosarcoma Protuberans: A Clinicopathologic Comparison

A. Sidoroff, K. Schmid, B. Jasani, 1994, The American journal of surgical pathology.

Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence

B. Jasani, W. Farrell, P. Hepburn, 2002, Molecular and Cellular Endocrinology.

A system for accurate immunolocalization of Tamm-Horsfall protein in renal biopsies

D. B. Moffat, B. Jasani, A. W. Asscher, 1985, The Histochemical Journal.

Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity

A. Clarke, C. Wallgren‐Pettersson, B. Jasani, 1993, Journal of the Neurological Sciences.

Parathyroid hyperplasia in multiple endocrine neoplasia type 1: a pathological and immunohistochemical reappraisal

B. Jasani, H. Harach, 1992, Histopathology.

Advances in immunocytochemistry of thyroid tumours 1987-1994.

B. Jasani, 1997, Current topics in pathology. Ergebnisse der Pathologie.

Immunofluorescence, In Situ Hybridization and Alternative Forms of ‘Labeled’ Microscopy

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Quantitative immunohistochemical evaluation by image analysis of metallothionein in copper-loaded rat kidney.

K. Schmid, D. Ofner, B. Jasani, 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Light microscopic immunocytochemical demonstration of thyroid-stimulating hormone (TSH) receptors on normal rat thyroid cells.

K. Schmid, B. Jasani, E. Williams, 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Use of the dinitrophenyl hapten sandwich staining procedure (DHSS) to localize estrogen receptors in paraffin-embedded tissues.

R. Nicholson, J. Gee, B. Jasani, 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma.

B. Jasani, L. Campbell, M. Gumbleton, 2015, American journal of cancer research.

Post-mortem analysis of apoptotic changes associated with human skin bruises.

B. Jasani, M. Kobayashi, B. Knight, 2000, Forensic science international.

Immunohistochemical detection of metallothionein expression and its correlation with ras activation in melanoma

K. Horgan, B. Jasani, L. Hughes, 1994, Journal of surgical oncology.

Implementation of Precision Cancer Diagnostic Test

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

SV40 large T antigen‐specific human T cell memory responses

M. Mason, B. Jasani, A. Gibbs, 2008, Journal of medical virology.

Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma.

M. Mason, B. Jasani, A. Gibbs, 2005, Vaccine.

Molecular Detection of Siman Virus 40 in Human Mesothelioma

B. Jasani, K. Ross, 2005 .

SIMIAN VIRUS 40 AND HUMAN PLEURAL MESOTHELIOMA. AUTHOR'S REPLY

B. Jasani, C. Mulatero, 1999 .

Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue.

D. Wynford‐Thomas, B. Jasani, H. Navabi, 1996, Thorax.

Simian virus 40 and human pleural mesothelioma

B. Jasani, 1999, Thorax.

Silver development in microscopy and bioanalysis: past and present

B. Jasani, G. Newman, 1998, The Journal of pathology.

Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining

D. Berney, M. Varma, B. Jasani, 2004, Journal of Clinical Pathology.

Immunocytochemistry in Diagnostic Histopathology

K. Schmid, B. Jasani, 1993 .

A histochemical and immunocytochemical study of hepatic copper and metallothionein in the pre‐ and post‐natal rat

B. Jasani, M. Elmes, S. Haywood, 1991, Journal of Pathology.

Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells.

B. Jasani, L. Borysiewicz, H. Navabi, 1997, Advances in experimental medicine and biology.

Immunological eventsleading todestructive thyroiditis intheAUG rat

B. Jasani, A. McGregor, N. Solic, 1988 .

High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications

E. Manna, J. Rüschoff, B. Jasani, 2022, Histopathology.

Tamm‐horsfall protein is a marker of renal and extra‐renal rhabdoid tumours

H. B. Marsden, H. Marsden, B. Jasani, 1988, International journal of cancer.

THE VISUALISATION OF TRACE AMOUNTS OF DIAMINOBENZIDINE (DAB) POLYMER BY A NOVEL GOLD‐SULPHIDE‐SILVER METHOD

B. Jasani, E. Williams, G. Newman, 1983 .

Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal

B. Jasani, H. Harach, 1992, Histopathology.

Histochemical and immunocytochemical evaluation of copper and metallothionein in the liver and kidney of copper‐loaded rats

B. Jasani, W. Evering, James Trafford, 1990, The Journal of pathology.

Molybdenum-associated pituitary endocrinopathy in sheep treated with ammonium tetrathiomolybdate.

B. Jasani, M. Loughran, S. Haywood, 2004, Journal of comparative pathology.

Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit

Geraint T. Williams, G. Thomas, B. Jasani, 2001 .

Metallothionein expression in canine and feline mammary and melanotic tumours.

B. Jasani, J. Mullins, I. Fuentealba, 2001, Journal of comparative pathology.

THE PRESERVATION OF ULTRASTRUCTURE AND ANTIGENICITY

B. Jasani, E. Williams, G. Newman, 1982 .

Effect of extrathyroidal activity on the estimation of radioiodide clearance.

R. Harden, B. Jasani, W. Alexander, 1968, The Journal of clinical endocrinology and metabolism.

Human Wound Contraction: Collagen Organization, Fibroblasts, and Myofibroblasts

Bharat Jasani, B. Jasani, K. Harding, 1998, Plastic and reconstructive surgery.

High molecular weight cytokeratin antibody (clone 34βE12): a sensitive marker for differentiation of high‐grade invasive urothelial carcinoma from prostate cancer

M. Varma, M. Amin, B. Jasani, 2003, Histopathology.

Immunocytochemical identification of metallothionein- positive cells in rheumatoid synovium and analysis of their cell lineage

B. Jasani, A. Morgan, C. Winters, 1997, The Histochemical Journal.

Immunolocalization of Caveolin-1 in Rat and Human Mesothelium

B. Jasani, L. Campbell, M. Gumbleton, 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature

M. Varma, B. Jasani, B Jasani, 2005, Histopathology.

Dinitrophenyl (DNP) hapten sandwich staining (DHSS) procedure. A 10 year review of its principle reagents and applications.

D. M. Millar, B. Jasani, E. Williams, 1992, Journal of immunological methods.

[Moist autoclaving. A simplified method for antigen unmasking].

J. Piffkó, A. Bankfalvi, W. Böcker, 1994, Der Pathologe.

Alpha-actinin in nemaline bodies in congenital nemaline myopathy: immunological confirmation by light and electron microscopy

A. Clarke, C. Wallgren‐Pettersson, B. Jasani, 1995, Neuromuscular Disorders.

Interlaboratory concordance of PD‐L1 immunohistochemistry for non‐small‐cell lung cancer

I. Petersen, M. Tiemann, A. Warth, 2018, Histopathology.

Predictive Biomarkers and Targeted Therapies in Colorectal Cancer

B. Jasani, S. Richman, 2018, Predictive Biomarkers in Oncology.

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

M. Salto‐Tellez, P. Hamilton, D. McArt, 2015, Journal of Translational Medicine.

Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial.

L. Zitvogel, M. Mason, A. Clayton, 2005, Blood cells, molecules & diseases.

Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab

D. Lambrechts, M. D. James, B. Jasani, 2013, Clinical Cancer Research.

Metallothionein is expressed in adipocytes of brown fat and is induced by catecholamines and zinc.

B. Jasani, G. McCormack, J. Beattie, 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

Epstein-Barr virus in squamous cell carcinoma after renal transplantation.

B. Ramsahoye, B. Jasani, D. Thomas, 1995, Transplantation.

p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure.

M. Metintaş, S. Işıksoy, B. Jasani, 2001, Respiratory medicine.

Ultimobranchial body nests in human fetal thyroid: An autopsy, histological, and immunohistochemical study in relation to solid cell nests and mucoepidermoid carcinoma of the thyroid

B. Jasani, G. Vujanić, H. Harach, 1993, The Journal of pathology.

Multiple hormone storage by cells of the human pituitary.

B. Jasani, E. Williams, G. Newman, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Introduction: From ‘Tissue Diagnosis’ to Biomarkers

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

D. Lambrechts, M. D. James, J. Bridgewater, 2011, The Lancet.

An immunocytochemical method for localization of estrogen receptors in rat tissues using a dinitrophenyl (DNP)-labeled rat monoclonal primary antibody.

R. Nicholson, J. Gee, B. Jasani, 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

T. Molina, P. Gaulard, M. Tiemann, 2007, Leukemia.

Prophylactic HPV vaccination for women over 18 years of age.

A. Fiander, B. Jasani, M. Adams, 2009, Vaccine.

Metallothionein expression in human breast cancer.

H. Goulding, R. Blamey, C. Elston, 1995, British Journal of Cancer.

Immunohistochemically demonstrated metallothionein expression in malignant melanoma

W. Böcker, K. Schmid, B. Jasani, 1993, Histopathology.

A Review on Mammary Tumors in Rabbits: Translation of Pathology into Medical Care

B. Jasani, S. Schöniger, H. Schoon, 2019, Animals : an open access journal from MDPI.

Elevated serum CA 19‐9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation

B. Jasani, M. Puntis, J. Thomas, 1992, Cancer.

A simple post-embedding system for the rapid demonstration of tissue antigens under the electron microscope

B. Jasani, E. Williams, G. Newman, 1983, The Histochemical Journal.

External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme.

I. Ellis, B. Jasani, A. O'Grady, 2009, American journal of clinical pathology.

Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

T. Molina, P. Gaulard, G. Salles, 2007, Leukemia.

Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast

I. O. Ellis, J. M. Stark, G. Daxenbichler, 2005, Virchows Archiv A.

Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas

N. Hunt, A. Douglas-Jones, B. Jasani, 1997, Virchows Archiv.

Epidermal Growth Factor Receptor Status in Hyperparathyroidism: Immunocytochemical and In Situ Hybridization Study

A. Douglas-Jones, B. Jasani, M. Wheeler, 1996, World Journal of Surgery.

Chronic neutrophilic leukemia and multiple myeloma: An association with λ light chain expression

M. Wagstaff, B. Jasani, G. Standen, 1990, Cancer.

Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression.

C. Wardrop, M. Wagstaff, B. Jasani, 1990, Cancer.

Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data

T. Henkel, G. Viale, M. Untch, 2015, Modern Pathology.

In situ correlation of synthesis and storage of parathormone in parathyroid gland disease

I. Lauder, B. Jasani, L. Potter, 1993, The Journal of pathology.

High‐molecular‐weight cytokeratin antibody (clone 34βE12) as a urothelial marker: a note of caution

M. Varma, M. Amin, B. Jasani, 2004, Histopathology.

Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia.

F. Wyllie, D. Wynford‐Thomas, B. Jasani, 1990, Growth factors.

A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu‐M1, Ber EP4, Tamm‐Horsfall protein and thrombomodulin

B. Jasani, R. Attanoos, A. Gibbs, 1995, Histopathology.

A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection.

B. Jasani, J. Neal, L. Borysiewicz, 1996, The Journal of infection.

Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies

B. Jasani, E. Williams, R. Katoh, 1989, Histopathology.

Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa

Geraint T. Williams, K. Schmid, B. Jasani, 1998, The Journal of pathology.

HER2 testing in the UK: further update to recommendations

I. Ellis, M. Dowsett, S. Pinder, 2008, Journal of Clinical Pathology.

Updated recommendations for HER2 testing in the UK

Anthony Rhodes, Ian O. Ellis, Bharat Jasani, 2004 .

recommendationstesting in the UK: further update to

I. Ellis, M. Dowsett, S. Pinder, 2008 .

Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries

B. Jasani, K. Miller, A. Rhodes, 2000, Journal of clinical pathology.

Impact of HER2 copy number in IHC2+/FISH-amplified breast cancer on outcome of adjuvant trastuzumab treatment in a large UK cancer network

B. Jasani, M. Brunelli, P. Barrett-Lee, 2014, British Journal of Cancer.

Breast Cancer Biomarkers

J. Bartlett, B. Jasani, K. Miller, 2011 .

Evaluation of automated silver‐enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens

S. Shousha, B. Jasani, D. Peston, 2009, Histopathology.

Phospho-4 eBP 1 and eIF 4 E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma

B. Jasani, L. Campbell, M. Gumbleton, 2015 .

ISH-based HER2 diagnostics

J. Rüschoff, B. Jasani, O. Stoss, 2020, Der Pathologe.

ISH-basierte HER2-Diagnostik

J. Rüschoff, B. Jasani, O. Stoss, 2020, Der Pathologe.

HER2 testing, adjuvant trastuzumab use and results. Our experience in South Wales.

B. Jasani, G. Bertelli, J. Abraham, 2010, Clinics in oncology.

Technical aspects of predictive and prognostic markers in breast cancer: What UK NEQAS data shows

B. Jasani, M. Ibrahim, K. Miller, 2007 .

The Practical Challenges for Pathology: Multiple Rapidly Evolving Methods

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Effect of goitrogen administration on the circadian rhythm of serum thyroid stimulating hormone in the rat.

D. Wynford‐Thomas, B. Jasani, E. Williams, 1981, Acta endocrinologica.

IN VIVO PHOTOINDUCTION OF METALLOTHIONEIN IN HUMAN SKIN BY ULTRAVIOLET IRRADIATION

D. Wynford‐Thomas, B. Jasani, A. Anstey, 1996, The Journal of pathology.

Clinical studies of human papilloma vaccines in cervical cancer.

A. Fiander, B. Jasani, L. Borysiewicz, 2001, Advances in experimental medicine and biology.

Cancer Metastasis: Biological and Clinical Aspects, Gynaecological Cancer

B. Jasani, M. Adams, 2000 .

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

A. Fiander, B. Jasani, S. Man, 2003, Vaccine.

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

A. Fiander, B. Jasani, L. Borysiewicz, 2001, Vaccine.

Overexpression of the drug resistance‐associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatment

M. Tötsch, K. Schmid, B. Jasani, 2010, Journal of surgical oncology.

The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis

B. Jasani, J. Neal, S. Singhrao, 2004, Acta Neuropathologica.

Mesothelioma not associated with asbestos exposure.

B. Jasani, A. Gibbs, 2012, Archives of pathology & laboratory medicine.

Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation

B. Jasani, I. Frayling, L. Side, 2009, Nature Reviews Clinical Oncology.

Tumor Infiltrating Lymphocytes in Pet Rabbit Mammary Carcinomas: A Study with Relevance to Comparative Pathology

B. Jasani, S. Schöniger, H. Schoon, 2020, Animals : an open access journal from MDPI.

Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy

I. Modlin, B. Jasani, J. Neal, 2012, Purinergic Signalling.

Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B.

W. Böcker, K. Schmid, B. Jasani, 1995, Laboratory investigation; a journal of technical methods and pathology.

APOPTOSIS IN AUTOIMMUNE AND NON‐AUTOIMMUNE THYROID DISEASE

B. Jasani, M. Ludgate, 1997, The Journal of pathology.

Natural antibody status in patients with Hashimoto's thyroiditis.

T. Ternynck, S. Avrameas, B. Jasani, 1999, Journal of clinical & laboratory immunology.

Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.

M. Mason, A. Clayton, B. Jasani, 2001, Journal of immunological methods.

Non-deleterious inhibition of endogenous peroxidase activity (EPA) by cyclopropanone hydrate: a definitive approach.

K. Schmid, B. Jasani, A. Hittmair, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis.

B. Jasani, G. Williams, J. Lindstrom, 2003, QJM : monthly journal of the Association of Physicians.

Significance of metallothionein overexpression in human tumours

K. Schmid, B. Jasani, K. Schmid, 1997, Histopathology.

Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.

Anthony Rhodes, Bharat Jasani, B. Jasani, 2002, American journal of clinical pathology.

Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer

Geraint T. Williams, B. Jasani, W. Lewis, 2012, ISRN surgery.

Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing

B. Jasani, A. O'Grady, E. Kay, 2004, Journal of Clinical Pathology.

ROLE OF CALCIUM CHELATION IN HIGH‐TEMPERATURE ANTIGEN RETRIEVAL AT DIFFERENT pH VALUES

B. Jasani, J. Morgan, H. Navabi, 1997, The Journal of pathology.

E-Cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast

R. Mansel, A. Douglas-Jones, B. Jasani, 2005, Virchows Archiv.

Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions

M. Tötsch, W. Böcker, K. Schmid, 2004, Breast Cancer Research and Treatment.

Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast

A. Douglas-Jones, B. Jasani, J. Morgan, 1997, Virchows Archiv.

Measurement of estrogen receptor status by immunocytochemistry in paraffin wax sections.

Anthony Rhodes, Bharat Jasani, R. Nicholson, 2006, Methods in molecular medicine.

Role of Pathologist in Precision Molecular and Digital Image Analyses

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts

B. Jasani, R. Attanoos, A. Gibbs, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

Hyperproliferation and aneuploidy in multinodular goitre and thyroid follicular neoplasia: causal or incidental relationship?

B. Jasani, 1997, Clinical Endocrinology.

Quality Control of Immunohistochemical and In Situ Hybridization Predictive Biomarkers for Patient Treatment: Experience from International Guidelines and International Quality Control Schemes

B. Jasani, Marius Grzelinski, G. Bänfer, 2018, Predictive Biomarkers in Oncology.

Thrombomodulin as a marker of vascular and lymphatic tumours

B. Jasani, R. Attanoos, M. Appleton, 1996, Histopathology.

SV40 and human brain tumors

A. Gazdar, H. Pass, J. Testa, 1997, International journal of cancer.

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status

G. Viale, J. Rüschoff, B. Jasani, 2022, Virchows Archiv.

Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen?

J. Butel, B. Jasani, 2013, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

B. Jasani, M. Elmes, Clare E. Fuller, 1990, The Journal of pathology.

Primary angiosarcoma of the mediastinum: light and electron microscopic demonstration of Factor VIII-related antigen in neoplastic cells.

N. Johnson, B. Jasani, A. Gibbs, 1984, Human pathology.

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer

F. Penault-Llorca, J. Rüschoff, B. Jasani, 2018, Diagnostic Pathology.

Immunohistochemical localization of cell surface receptors using a novel method permitting simple, rapid and reliable LM/EM correlation

D. Wynford‐Thomas, B. Jasani, G. Newman, 1986, The Histochemical Journal.

External Quality Assurance Schemes: The Impact of Participation in the UK Versus Rest of the World: 5 Year Data from the UK National External Quality Assurance Scheme.

B. Jasani, A. O'Grady, E. Kay, 2009 .

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

M. Parmar, G. Taylor, R. Butler, 2014, British Journal of Cancer.

The role and mechanism of high-temperature antigen retrieval in diagnostic pathology

B. Jasani, A. Rhodes, 2001 .

Immunoelectronmicroscopy: immunogold and immunoperoxidase compared using a new post-embedding system.

B. Jasani, G. Newman, 1984, Medical laboratory sciences.

Metal compound intensification of the electron-density of diaminobenzidine.

B. Jasani, E. Williams, G. Newman, 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network Do the results of international clinical trials translate into a similar benefit for patients in South East Wales?

B. Jasani, J. Abraham, P. Barrett-Lee, 2011, British Journal of Cancer.

Standard Reference Material: Cell Line Development and Use of Reference Cell Lines as Standards for External Quality Assurance of Her2 IHC and ISH Testing

Michael Morgan, John M. S. Bartlett, Jeremy Walker, 2010 .

Immunohistochemical retrieval of the principal HIV antigens p24, gp41, and gp120 in formalin fixed tissue: an investigation using HIV infected lymphoblasts and postmortem brain tissue from AIDS cases.

B. Jasani, J. Neal, A. Parkes, 1998, Molecular pathology : MP.

Metallothionein overexpression in human brain tumours

H. Budka, Chris Jones, K. Schmid, 1997, Acta Neuropathologica.

Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival

W. Böcker, K. Schmid, B. Jasani, 2004, Virchows Archiv.

Comparison oftumourmarkers inmalignant mesothelioma andpulmonary adenocarcinoma

B. Jasani, A. Gibbs, R. Harach, 1985 .

Potential unreliability of normal tissue as positive control in diagnostic immunohistochemistry of poorly differentiated carcinoma

M. Varma, B. Jasani, S. Wozniak, 2010, Histopathology.

Prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) immunoreactivity in benign seminal vesicle\ejaculatory duct epithelium: a potential pitfall in the diagnosis of prostate cancer in needle biopsy specimens

M. Varma, B. Jasani, M. Morgan, 2004, Histopathology.

Immunohistologically definable light chain restriction in autoimmune disease: Author's reply

B. Jasani, 1988, The Journal of pathology.

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

A. Bankfalvi, K. Schmid, B. Jasani, 2018, Pneumologie.

Role of Pathologist in Precision Cancer Diagnosis

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Precision Cancer Medicine: Role of the Pathologist

B. Jasani, R. Huss, C. Taylor, 2021 .

The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury

B. Jasani, A. Morgan, K. Leyshon-Sørland, 1994, The Histochemical Journal.

Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia.

R. Mansel, B. Jasani, S. Kumar, 1987, British Journal of Cancer.

Abstract P3-10-21: Audit of the Accuracy of Immunohistochemical (IHC) Testing of HER2 Status of Breast Cancer in the United Kingdom: An Interim Analysis

B. Jasani, K. Miller, M. Ibrahim, 2010 .

Electron-density of Diaminobenzidine

B. Jasani, E. Williams, G. Newman, 1983 .

CA125 in ovarian tumour tissue at second laparotomy.

B. Jasani, G. Williams, M. Shelley, 1989, British Journal of Cancer.

Lack of sampling site variation in chorion villus biopsy as assessed by DNA, enzymatic, morphological and cytogenetical analyses

P. Harper, B. Jasani, M. Upadhyaya, 1987, Prenatal diagnosis.

Immortalized Human Pituitary Cells Express Glycoproteinα -Subunit and Thyrotropin β (TSHβ)

J. Bond, B. Jasani, P. Hepburn, 1998 .

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).

K. Schmid, B. Jasani, K. Schmitz, 2009, Human pathology.

Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma

K. Schmid, B. Jasani, H. Reis, 2009, International Journal of Colorectal Disease.

Identification of apoptotic cell nuclei in postmortem skin biopsies using the tunel reaction: Effect of post-mortem time interval

B. Jasani, B. Knight, T. Sawaguchi, 1997 .

Wild type P53 and metallothionein are expressed simultaneously in UV irradiated skin: A possible link to photocarcinogenesis

B. Jasani, A. Anstey, R. Marks, 1993 .

The Advent of Biomarker Testing

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Pathology of the spleen in large granular lymphocyte leukaemia.

B. Jasani, G. Standen, D. Griffiths, 1989, Journal of clinical pathology.

Histological demonstration of immunoreactive metallothionein in rat and human tissues.

B. Jasani, M. Elmes, J. Clarkson, 1987, Experientia. Supplementum.

Receptor secretion hypothesis for regulation of hormone action.

D. Wynford‐Thomas, B. Jasani, E. Williams, 1983, Medical hypotheses.

Analytical Phase: Protocol and Antigen Retrieval

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

FOCUS 3: A study to determine the feasibility of molecular selection of therapy using K-RAS, B-RAF, and topo-1 in patients with advanced colorectal cancer (ACRC).

M. Parmar, Geraint T. Williams, R. Butler, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immortalized Human Pituitary Cells Express Glycoprotein a-Subunit and Thyrotropin b ( TSH b )

J. Bond, B. Jasani, P. Hepburn, 1998 .

Immunoreactive p 53 and metallothionein expression in duct carcinoma in situ of the breast No correlation

B. Jasani, J. Morgan, H. Navabi, 2022 .

Immunohistochemical localization of cell using a novel method permitting simple, LM/EM correlation surface receptors rapid and reliable

D. Wynford‐Thomas, B. Jasani, G. Newman, 1986 .

Immunocytochemical detection of metallothionein (MT1 and MT2) in copper-enhanced sheep brains.

B. Jasani, S. Haywood, Z. Dincer, 1999, Journal of comparative pathology.

validation of

M. D. James, R. Butler, B. Jasani, 2023 .

Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa

Geraint T. Williams, K. Schmid, B. Jasani, 1998, The Journal of pathology.

Nemaline myopathy : current concepts

France, Australia, Finland., 2022 .

ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED COMBINATION CHEMOTHERAPY (CT) IN PATIENTS WITH K-ras WILD-TYPE ADVANCED COLORECTAL CANCER (ACRC): EFFECTS ON OVERALL SURVIVAL. MRC COIN (CR10) TRIAL RESULTS

B. Jasani, J. Cheadle, H. Wasan, 2009 .

Pre-Analytical Phase: Biopsy/Tissue Handling and Processing

B. Jasani, R. Huss, C. Taylor, 2021, Precision Cancer Medicine.

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

D. Lambrechts, M. D. James, J. Bridgewater, 2011, The Lancet.

Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast

R. Nicholson, M. Dünser, J. Gee, 2005, Virchows Archiv A.

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

D. Barnes, B. Jasani, A. Rhodes, 2000, Journal of clinical pathology.

Histological demonstration of immunoreactive metallothionein in sections of human and rat tissue

B. Jasani, M. Elmes, J. Clarkson, 1985, Environmental Geochemistry and Health.

Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial

M. D. James, R. Butler, P. Quirke, 2015, Journal of Clinical Pathology.

HER2 gene amplification in breast cancer: a rogues' gallery of challenging diagnostic cases: UKNEQAS interpretation guidelines and research recommendations.

B. Jasani, N. Atkey, S. Di Palma, 2012, American journal of clinical pathology.